Globus Medical (GMED) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Globus Medical · Health Care · ref. ETF XLV · 69 calls · price $76.32
What the company does: Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
📈 Globus Medical (GMED) stock price
$76.32+31.4% over range
Oct 14, 25low $58.09 · high $96.82Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 8 analysts
📊 JPI status : Globus Medical has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 GMED price target & analyst consensus — price $76.32
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$117+53.3%
Median target · of 8 targets$96.5+26.4%
Lowest target · 1 firm of 8$80+4.8%
Current price$76.32
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
8100%
$80 ↔ $117
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Truist Securities — 65% of its targets hit on this sector (110 calls tested). It aims for $100 (+31 %), call made on July 17, 2026, maturing on July 17, 2027 (89 d ago).
The 4 reliable analysts
$92+21 %
The 4 other firms
$97+27 %
How to read it: the 4 reliable firms are not filtered by optimism — 4 aim above the price, 0 below, hence their $92 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy675%
Hold225%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 GMED price target all
All 69 calls, one by one, with our verdict on each firm.
→ See all 69 targets, analyst by analyst💡 The best analysts on GMED most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in GMED? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Globus Medical? The JPI assistant answers using our backtest data.
📈 Globus Medical fundamentals: valuation, margins & growth › open the full page
P/E 19.6Net margin 17.0 %Revenue growth +5.9 %Average P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 19 %
2023
Rev +53%Profit −35%
2024
Rev +61%Profit −16%
2025
Rev +17%Profit +422%
🔎 Detailed analyses
🏛️ Which US Congress members hold Globus Medical (GMED)?
1 Congress member has disclosed GMED buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Josh Gottheimer 1× · 56%
✅ Historical analyst reliability on GMED
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| WallachBeth Capital | 100% | +47.9% | 2 |
| Stifel ↗ | 100% | +24.0% | 5 |
| Brean Capital | 100% | +17.4% | 2 |
| Roth MKM ↗ | 100% | +17.3% | 3 |
| B of A Securities ↗ | 100% | +12.9% | 6 |
| Oppenheimer ↗ | 75% | +23.2% | 4 |
| Credit Suisse | 75% | +23.1% | 8 |
| Canaccord Genuity ↗ | 75% | +17.9% | 16 |
| UBS ↗ | 67% | +16.5% | 3 |
| Wells Fargo ↗ | 62% | +6.5% | 13 |
See the other 12 firms
| Cantor Fitzgerald ↗ | 0% | -15.2% | 2 |
| Barclays ↗ | 30% | -23.8% | 10 |
| Piper Sandler ↗ | 38% | -1.3% | 8 |
| Needham ↗ | 38% | +4.7% | 8 |
| Morgan Stanley ↗ | 44% | +1.6% | 9 |
| Goldman Sachs ↗ | 50% | -16.9% | 2 |
| Truist Securities ↗ | 50% | -10.8% | 2 |
| Citigroup ↗ | 50% | -2.6% | 2 |
| Leerink Swann | 50% | +3.6% | 6 |
| RBC Capital ↗ | 50% | +8.1% | 6 |
| SVB Leerink | 50% | +13.3% | 4 |
| BTIG ↗ | 58% | +14.3% | 12 |
📊 What $1,000 invested in Globus Medical would be worth › open the full page
In short — $1,000 invested in Globus Medical 10 years ago would be worth $2,840 today, i.e. +11%/yr on average. Best year: 2017 (+66%), worst: 2023 (-28%). Price performance, excluding dividends.
If I'd invested $1,000 in Globus Medical
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $955 | -4% |
| 3 years ago | $1,064 | +6% |
| 5 years ago | $1,211 | +21% |
Return by year (Globus Medical)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -10% | $905 (-10%) |
| 2025 | +6% | $955 (-4%) |
| 2024 | +55% | $1,483 (+48%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Globus Medical
Loading news…
📋 All analyst calls on GMED
Filtered on — · ✕ show all
RBC Capital ↗
Oct 1, 26
▲ Outperform · 🎯$85
Price at call : $74.41 — upside +14%
Today : $76.32 — upside +11%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Oct 1, 27
matures : Oct 1, 27
Wells Fargo ↗
Aug 7, 26
▲ Overweight · 🎯$99
Price at call : $86.15 — upside +15%
Today : $76.32 — upside +30%
🎯 on GMED : 100% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
■ Neutral neutral · not a buy · 🎯$82
Price at call : $81.42 — gap to target +1%
Today : $76.32 — gap to target +7%
🎯 on GMED : no call matured yet · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
Truist Securities ↗
Jul 16, 26
▲ Buy · 🎯$100
Price at call : $77 — upside +30%
Today : $76.32 — upside +31%
🎯 on GMED : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
RBC Capital ↗
Jul 13, 26
▲ Outperform · 🎯$115
Price at call : $75.82 — upside +52%
Today : $76.32 — upside +51%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
BMO Capital ↗
Jul 9, 26
▲ Outperform · 🎯$94
Price at call : $78.11 — upside +20%
Today : $76.32 — upside +23%
🎯 on GMED : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
■ Hold neutral · not a buy · 🎯$80
Price at call : $76.2 — gap to target +5%
Today : $76.32 — gap to target +5%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48% · +12.3% (100 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
Piper Sandler ↗
Jun 15, 26
▲ Overweight · 🎯$100
Price at call : $77.32 — upside +29%
Today : $76.32 — upside +31%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jun 15, 27
matures : Jun 15, 27
See the other 61 calls, newest to oldest
RBC Capital ↗
May 8, 26
▲ Outperform · 🎯$120
Price at call : $76.68 — upside +56%
Today : $76.32 — upside +57%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
Wells Fargo ↗
May 8, 26
▲ Overweight · 🎯$103
Price at call : $77.95 — upside +32%
Today : $76.32 — upside +35%
🎯 on GMED : 100% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
▲ Buy · 🎯$117
Price at call : $77.95 — upside +50%
Today : $76.32 — upside +53%
🎯 on GMED : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
Wells Fargo ↗
Feb 26, 26
▲ Overweight · 🎯$104
Price at call : $95.46 — upside +9%
Today : $76.32 — upside +36%
🎯 on GMED : 100% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Overweight · 🎯$123
Price at call : $96.71 — upside +27%
Today : $76.32 — upside +61%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Buy · 🎯$114
Price at call : $96.22 — upside +18%
Today : $76.32 — upside +49%
🎯 on GMED : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Buy · 🎯$112
Price at call : $90.68 — upside +24%
Today : $76.32 — upside +47%
🎯 on GMED : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
Canaccord Genuity ↗
Jan 9, 26
▲ Buy · 🎯$112
Price at call : $91.72 — upside +22%
Today : $76.32 — upside +47%
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
Piper Sandler ↗
Jan 8, 26
▲ Overweight · 🎯$115
Price at call : $94.47 — upside +22%
Today : $76.32 — upside +51%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
Canaccord Genuity ↗
Dec 17, 25
▲ Buy · 🎯$105
Price at call : $86.88 — upside +21%
Today : $76.32 — upside +38%
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
RBC Capital ↗
Dec 17, 25
▲ Outperform · 🎯$100
Price at call : $85.06 — upside +18%
Today : $76.32 — upside +31%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
Freedom Capital Markets
Dec 17, 25
■ Hold neutral · not a buy · 🎯$87
Price at call : $85.06 — gap to target +2%
Today : $76.32 — gap to target +14%
🎯 on GMED : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
Morgan Stanley ↗
Dec 2, 25
▲ Overweight · 🎯$100
Price at call : $87.75 — upside +14%
Today : $76.32 — upside +31%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
Truist Securities ↗
Nov 18, 25
▲ Buy · 🎯$105
Price at call : $83.42 — upside +26%
Today : $76.32 — upside +38%
🎯 on GMED : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Nov 18, 26
matures : Nov 18, 26
▲ Overweight · 🎯$114
Price at call : $84.94 — upside +34%
Today : $76.32 — upside +49%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
RBC Capital ↗
Nov 7, 25
▲ Outperform · 🎯$92
Price at call : $86.36 — upside +7%
Today : $76.32 — upside +21%
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Wells Fargo ↗
Nov 7, 25
▲ Overweight · 🎯$79
Price at call : $86.36 — upside -9%
Today : $76.32 — upside +4%
🎯 on GMED : 100% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
B of A Securities ↗
Nov 7, 25
▲ Buy · 🎯$91
Price at call : $83.89 — upside +8%
Today : $76.32 — upside +19%
🎯 on GMED : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Truist Securities ↗
Nov 7, 25
▲ Buy · 🎯$93
Price at call : $83.89 — upside +11%
Today : $76.32 — upside +22%
🎯 on GMED : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
RBC Capital ↗
Oct 10, 25
▲ Outperform · 🎯$88
Price at call : $57.49 — upside +53%
Today : $76.32 — upside +15%
Expected +53% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
+32.6%
stock +33% · XLV +21%
matured Oct 10, 26
Wells Fargo ↗
Aug 8, 25
▲ Overweight · 🎯$66
Price at call : $59.43 — upside +11%
Today : $76.32 — upside -14%
Expected +11% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 100% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
+45.0%
stock +45% · XLV +29%
matured Aug 8, 26
Canaccord Genuity ↗
Jul 22, 25
▲ Buy · 🎯$90
Price at call : $54.04 — upside +67%
Today : $76.32 — upside +18%
Expected +67% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+39.6%
stock +40% · XLV +18%
matured Jul 22, 26
■ Hold neutral · not a buy
🎯 on GMED : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Jul 21, 26
matures : Jul 21, 26
Morgan Stanley ↗
Jul 15, 25
▲ Overweight · 🎯$68
Price at call : $55.87 — upside +22%
Today : $76.32 — upside -11%
Expected +22% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 42% · -0.8% (200 calls)
+40.6%
stock +41% · XLV +19%
matured Jul 15, 26
JMP Securities
May 27, 25
■ Market Perform neutral · not a buy
🎯 on GMED : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 27, 26
matures : May 27, 26
■ Neutral neutral · not a buy
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : May 27, 26
matures : May 27, 26
Truist Securities ↗
May 12, 25
■ Hold neutral · not a buy · 🎯$68
Price at call : $58.25 — gap to target +17%
Today : $76.32 — gap to target -11%
🎯 on GMED : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : May 12, 26
matures : May 12, 26
Piper Sandler ↗
May 9, 25
▲ Overweight · 🎯$80
Price at call : $59.01 — upside +36%
Today : $76.32 — upside +5%
Expected +36% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 42.5% · +4.1% (120 calls)
+29.9%
stock +30% · XLV +5%
matured May 9, 26
▲ Buy · 🎯$77
Price at call : $55.82 — upside +38%
Today : $76.32 — upside +1%
Expected +38% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+37.4%
stock +37% · XLV +8%
matured May 9, 26
Truist Securities ↗
Apr 11, 25
■ Hold neutral · not a buy · 🎯$80
Price at call : $72.59 — gap to target +10%
Today : $76.32 — gap to target +5%
🎯 on GMED : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Apr 11, 26
matures : Apr 11, 26
▲ Buy · 🎯$88
Price at call : $74.28 — upside +18%
Today : $76.32 — upside +15%
Expected +18% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+23.1%
stock +23% · XLV +8%
matured Apr 9, 26
Truist Securities ↗
Mar 18, 25
■ Hold neutral · not a buy · 🎯$82
Price at call : $73.34 — gap to target +12%
Today : $76.32 — gap to target +7%
🎯 on GMED : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Mar 18, 26
matures : Mar 18, 26
■ Hold neutral · not a buy
🎯 on GMED : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Mar 18, 26
matures : Mar 18, 26
Citizens Capital Markets
Feb 24, 25
■ Market Perform neutral · not a buy
🎯 on GMED : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 24, 26
matures : Feb 24, 26
▲ Overweight · 🎯$103
Price at call : $80.02 — upside +29%
Today : $76.32 — upside +35%
Expected +29% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48.3% · +1.1% (203 calls)
+14.8%
stock +15% · XLV +7%
matured Feb 24, 26
▲ Buy · 🎯$94
Price at call : $80.02 — upside +17%
Today : $76.32 — upside +23%
Expected +17% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 100% (1 call matured) · 📊 on Health : 48% · +12.3% (100 calls)
+16.7%
stock +17% · XLV +7%
matured Feb 21, 26
Wells Fargo ↗
Feb 21, 25
▲ Overweight · 🎯$93
Price at call : $80.28 — upside +16%
Today : $76.32 — upside +22%
Expected +16% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 100% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
+16.3%
stock +16% · XLV +8%
matured Feb 21, 26
▲ Buy · 🎯$94
Price at call : $80.28 — upside +17%
Today : $76.32 — upside +23%
Expected +17% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+16.3%
stock +16% · XLV +8%
matured Feb 21, 26
■ Hold neutral · not a buy
🎯 on GMED : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Feb 21, 26
matures : Feb 21, 26
■ Hold neutral · not a buy
🎯 on GMED : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Feb 6, 26
matures : Feb 6, 26
Canaccord Genuity ↗
Jan 10, 25
▲ Buy · 🎯$101
Price at call : $87.18 — upside +16%
Today : $76.32 — upside +32%
Expected +16% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+5.2%
stock +5% · XLV +11%
matured Jan 10, 26
B of A Securities ↗
Jan 9, 25
■ Neutral neutral · not a buy · 🎯$97
Price at call : $87.07 — gap to target +11%
Today : $76.32 — gap to target +27%
🎯 on GMED : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Jan 9, 26
matures : Jan 9, 26
▲ Buy · 🎯$91
Price at call : $82.42 — upside +10%
Today : $76.32 — upside +19%
Expected +10% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+5.0%
stock +5% · XLV +11%
matured Dec 12, 25
Canaccord Genuity ↗
Dec 9, 24
▲ Buy · 🎯$92
Price at call : $82.89 — upside +11%
Today : $76.32 — upside +21%
Expected +11% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+5.9%
stock +6% · XLV +6%
matured Dec 9, 25
Canaccord Genuity ↗
Nov 6, 24
▲ Buy · 🎯$85
Price at call : $81.97 — upside +4%
Today : $76.32 — upside +11%
Expected +4% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+2.3%
stock +2% · XLV -2%
matured Nov 6, 25
▲ Buy · 🎯$78
Price at call : $74.05 — upside +5%
Today : $76.32 — upside +2%
Expected +5% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
-21.2%
stock -21% · XLV -7%
matured Oct 14, 25
▲ Buy · 🎯$77
Price at call : $72.09 — upside +7%
Today : $76.32 — upside +1%
Expected +7% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
-15.0%
stock -15% · XLV -12%
matured Aug 28, 25
▲ Buy · 🎯$75
Price at call : $72.14 — upside +4%
Today : $76.32 — upside -2%
Expected +4% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
-21.5%
stock -22% · XLV -10%
matured Jul 15, 25
▲ Buy · 🎯$72
Price at call : $65.27 — upside +10%
Today : $76.32 — upside -6%
Expected +10% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
-9.8%
stock -10% · XLV -7%
matured May 29, 25
▲ Buy · 🎯$63
Price at call : $64.36 — upside -2%
Today : $76.32 — upside -17%
Expected -2% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
-13.3%
stock -13% · XLV -7%
matured May 8, 25
▲ Buy · 🎯$60
Price at call : $51.65 — upside +16%
Today : $76.32 — upside -21%
Expected +16% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+38.6%
stock +39% · XLV +1%
matured Mar 18, 25
Canaccord Genuity ↗
Dec 20, 23
▲ Buy · 🎯$71
Price at call : $51.87 — upside +37%
Today : $76.32 — upside -7%
Expected +37% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+58.0%
stock +58% · XLV +3%
matured Dec 19, 24
Canaccord Genuity ↗
Mar 30, 23
▲ Buy · 🎯$67
Price at call : $55.72 — upside +20%
Today : $76.32 — upside -12%
Expected +20% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
-4.7%
stock -5% · XLV +14%
matured Mar 29, 24
Canaccord Genuity ↗
Aug 5, 21
▲ Buy · 🎯$90
Price at call : $80.49 — upside +12%
Today : $76.32 — upside +18%
Expected +12% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
-21.1%
stock -21% · XLV -1%
matured Aug 5, 22
Canaccord Genuity ↗
May 5, 21
▲ Buy · 🎯$80
Price at call : $72.9 — upside +10%
Today : $76.32 — upside +5%
Expected +10% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
-10.6%
stock -11% · XLV +5%
matured May 5, 22
Canaccord Genuity ↗
Aug 6, 20
▲ Buy · 🎯$60
Price at call : $56.91 — upside +5%
Today : $76.32 — upside -21%
Expected +5% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+40.9%
stock +41% · XLV +25%
matured Aug 6, 21
▲ Buy · 🎯$46
Price at call : $38.4 — upside +20%
Today : $76.32 — upside -40%
Expected +20% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+56.6%
stock +57% · XLV +37%
matured Mar 18, 21
Canaccord Genuity ↗
Nov 7, 19
▲ Buy · 🎯$60
Price at call : $55.72 — upside +8%
Today : $76.32 — upside -21%
Expected +8% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+4.2%
stock +4% · XLV +17%
matured Nov 6, 20
▲ Buy · 🎯$37
Price at call : $30.13 — upside +23%
Today : $76.32 — upside -52%
Expected +23% · Actual +76% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 58% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+75.5%
stock +76% · XLV +13%
matured Sep 7, 18
Canaccord Genuity ↗
May 4, 17
▲ Buy
Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+52.3%
stock +52% · XLV +7%
matured May 4, 18
Canaccord Genuity ↗
Oct 31, 14
▲ Buy · 🎯$28
Price at call : $22.17 — upside +26%
Today : $76.32 — upside -63%
Expected +26% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on GMED : 75% (12 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+3.9%
stock +4% · XLV +8%
matured Oct 31, 15
Frequently asked questions
Should I buy Globus Medical stock?
This isn't buy advice. For Globus Medical, the analyst consensus is "Buy", with an average price target of $96.50 (+26% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Globus Medical). We show the numbers — you decide.
Is it too late to buy Globus Medical? How high can it go?
The most bullish analyst target on Globus Medical is $117 (+53% above today's price); the average is $96.50. That's the upside they see. Check how reliable those analysts have actually been on Globus Medical on our site before trusting it.
Is Globus Medical still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 22 analysts have a real record on Globus Medical, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Globus Medical? The case for and against
The arguments for and against, one by one, from the numbers: why invest in GMED (and why hesitate).
What has Globus Medical's past performance been?
Historical returns and a "how much if I had invested" calculator: GMED performance & returns.
What is the best month to buy GMED?
The 12 months ranked by the stock's past returns: best & worst month to buy GMED.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX